Cansortium, Inc.

  • Market Cap: N/A
  • Industry: Other Agricultural Products
  • ISIN: CA13809L1094
USD
0.04
-0.01 (-20.0%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Cansortium, Inc. stock-summary
stock-summary
Cansortium, Inc.
Other Agricultural Products
Cansortium Inc. operates an industrial hemp production in Canada. The Company produces and sells medical cannabis in Florida, Texas and Pennsylvania. The Company also operates as a seed bank and sells medical cannabis in Colombia. The Company operates under Fluent brand. Through its subsidiaries, the Company operates cultivation, processing and dispensary facilities. The Company’s medical cannabis products are offered in oral drops, capsules, suppositories, topicals, syringes, dried flower, prerolls and cartridges. Its subsidiaries include Cansortium Pennsylvania, LLC, Cansortium Texas, LLC, Cansortium Canada Holdings Inc., Cansortium Canada Servicing, Inc. and Cansortium Florida, LLC.
Company Coordinates stock-summary
Company Details
82 NE 26th St Unit 110 , MIAMI FL : 33137-4442
stock-summary
Tel: 1 305 9022720
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Strategic Entities

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 0 Foreign Institutions (0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
26 Million
(Quarterly Results - Sep 2024)
Net Profit:
-12 Million
stock-summary
Industry

Other Agricultural Products

stock-summary
Market cap

USD 25 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-11.40

stock-summary
Return on Equity

409.49%

stock-summary
Price to Book

-4.29